Has VZV epidemiology changed in Italy? Results of a seroprevalence study

Abstract

The aim of the study was to evaluate if and how varicella prevalence has changed in Italy. In particular a seroprevalence study was performed, comparing it to similar surveys conducted in pre-immunization era. During 2013-2014, sera obtained from blood samples taken for diagnostic purposes or routine investigations were collected in collaboration with at least one laboratory/center for each region, following the approval of the Ethics Committee. Data were stratified by sex and age. All samples were processed in a national reference laboratory by an immunoassay with high sensitivity and specificity. Statutory notifications, national hospital discharge database and mortality data related to VZV infection were analyzed as well. A total of 3707 sera were collected and tested. In the studied period both incidence and hospitalization rates decreased and about 5 deaths per year have been registered. The seroprevalence decreased in the first year of life in subjects passively protected by their mother, followed by an increase in the following age classes. The overall antibody prevalence was 84%. The comparison with surveys conducted with the same methodology in 1996-1997 and 2003-2004 showed significant differences in age groups 1-19 y. The study confirms that in Italy VZV infection typically occurs in children. The impact of varicella on Italian population is changing. The comparison between studies performed in different periods shows a significant increase of seropositivity in age class 1 -4 years, expression of vaccine interventions already adopted in some regions.

Varicella vaccination in Italy and Germany – different routes to success: a systematic review

“…Prior to the introduction of UVV, seroprevalence increased with age, from 20% to 40% in children 0.5-4 years to >80% by the age of 18 years (Table 1) [36,38,79,91,98]. Of 11 European countries evaluated between 1996 and 2003, Italy was the only one in which less than half (38%) of children aged 5 years were seropositive for VZV.…”

Assessment of seroprevalence against poliovirus among Italian adolescents and adults

“…Therefore, they can act as a polio reservoir and infect unvaccinated and immunocompromised contacts. 21 The present study has some limitations. As it is based on a convenience sample, it is unknown if these results are generalizable to the current status of poliovirus immunity in the Italian population as a whole.…”

The burden of herpes zoster disease in Norway

“…The post-marketing evidence of universal varicella vaccination demonstrates a large public health impact in reducing the burden of disease and associated costs. A 74% reduction in varicella incidence has been reported by countries with one-dose varicella vaccination program, and reduction >90% by countries with two-dose vaccine program in place [135,[150][151][152][153][154][155][156][157][158][159].…”